Tag: Incyte Diagnostics

Pathology Consolidation Underway in Washington

CEO SUMMARY: Two regional pathology super-practices have emerged in Washington State. In each case, acquisitions and mergers are fueling the growth of the two large pathology groups. In Western Washington and the Seattle metro, CellNetix is the dominant pathology group, with 53 physicians. The sphere of influence for Incyte Diagnostics and its 40 pathologists is

View Article

Incyte to Develop New Ways For Pathologists to Add Value

CONSOLIDATION OF PRIVATE PRACTICE PATHOLOGY GROUPS in Washington State has been ongoing. Because of their acquisitions, CellNetix and Incyte Diagnostics are now the state’s two largest pathology groups.

The next challenge for these two pathology super-groups will be developing new ways to add value to a healthcare system moving away from fee-for-service reimbursement and to integrated

View Article

July 21, 2014 “Intelligence: Late Breaking Lab News”

Consolidation of private pathology group practices continues. On July 8, NeoGenomics of Fort Myers, Florida, announced that it had acquired Path Logic of Sacramento. Then, one day later, Incyte Diagnostics of Spokane, Washington, disclosed that it was buying Accupath Pathology Services, Inc., of Seattle, Washington. Path Logic was founded by Peter Kolbek, M.D., in 1999

View Article

May 06, 2013 “Intelligence: Late Breaking Lab News”

Much is happening in the anatomic pathology market in the Pacific Northwest. PAML, LLC (Spokane, Washington), and CellNetix (Seattle, Washington) finally executed the agreement whereby PAML made an equity investment in CellNetix. Now, the two lab companies will collaborate on developing a reference and esoteric anatomic pathology testing service with national ambitions. Within days of

View Article